Semaglutide & Tirzepatide Patent Considerations
The Legal Landscape of Semaglutide & Tirzepatide: What Pharmacy Owners Need to Know If you’ve been watching the ongoing saga of compounded GLP-1 medications, you already know that the semaglutide and tirzepatide situations are heating up. Between Novo Nordisk’s and Eli Lilly’s patent protections, FDA rulings, and lawsuits flying around, pharmacy owners need to stay […]
Semaglutide & Tirzepatide Patent Considerations Read More »